Mental Health Challenges in Cancer Patients: A Cross-Sectional Analysis of Depression and Anxiety
Abstract
:Simple Summary
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Sample Characteristics
2.3. Assessment
2.4. Methods
2.5. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Grassi, L.; Spiegel, D.; Riba, M. Advancing psychosocial care in cancer patients. F1000Research 2017, 6, 2083. [Google Scholar] [CrossRef] [PubMed]
- Falzone, L.; Salomone, S.; Libra, M. Evolution of cancer pharmacological treatments at the turn of the third millennium. Front. Pharmacol. 2018, 9, 1300. [Google Scholar] [CrossRef] [PubMed]
- Correia, J.H.; Rodrigues, J.A.; Pimenta, S.; Dong, T.; Yang, Z. Photodynamic Therapy Review: Principles, Photosensitizers, Applications, and Future Directions. Pharmaceutics 2021, 13, 1332. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Cancer Incidence Statistics. Available online: https://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence (accessed on 13 March 2024).
- Vin-Raviv, N.; Hillyer, G.C.; Hershman, D.L.; Galea, S.; Leoce, N.; Bovbjerg, D.H.; Kushi, L.H.; Kroenke, C.; Lamerato, L.; Ambrosone, C.B.; et al. Racial disparities in posttraumatic stress after diagnosis of localized breast cancer: The BQUAL study. J. Natl. Cancer Inst. 2013, 105, 563–572. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Peters, L.; Brederecke, J.; Franzke, A.; de Zwaan, M.; Zimmermann, T. Psychological Distress in a Sample of Inpatients With Mixed Cancer—A Cross-Sectional Study of Routine Clinical Data. Front. Psychol. 2020, 11, 591771. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Chida, Y.; Hamer, M.; Wardle, J.; Steptoe, A. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat. Clin. Pract. Oncol. 2008, 5, 466–475. [Google Scholar] [CrossRef] [PubMed]
- McDermott, C.L.; Bansal, A.; Ramsey, S.D.; Lyman, G.H.; Sullivan, S.D. Depression and health care utilization at end of life among older adults with advanced non–small-cell lung cancer. J. Pain Symptom Manag. 2018, 56, 699–708.e1. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Smith, H.R. Depression in cancer patients: Pathogenesis, implications and treatment (Review). Oncol. Lett. 2015, 9, 1509–1514. [Google Scholar] [CrossRef]
- Walker, J.; Hansen, C.H.; Martin, P.; Sawhney, A.; Thekkumpurath, P.; Beale, C.; Symeonides, S.; Wall, L.; Murray, G.; Sharpe, M. Prevalence of depression in adults with cancer: A systematic review. Ann. Oncol. 2013, 24, 895–900. [Google Scholar] [CrossRef] [PubMed]
- Mehnert, A.; Hartung, T.J.; Friedrich, M.; Vehling, S.; Brähler, E.; Härter, M.; Keller, M.; Schulz, H.; Wegscheider, K.; Weis, J.; et al. One in two cancer patients is significantly distressed: Prevalence and indicators of distress. Psycho-Oncology 2018, 27, 75–82. [Google Scholar] [CrossRef] [PubMed]
- Ashbury, F.D.; Madlensky, L.; Raich, P.; Thompson, M.; Whitney, G.; Hotz, K.; Kralj, B.; Edell, W.S. Antidepressant prescribing in community cancer care. Support. Care Cancer 2003, 11, 278–285. [Google Scholar] [CrossRef] [PubMed]
- Kissane, D.W.; Bylund, C.L.; Banerjee, S.C.; Bialer, P.A.; Levin, T.T.; Maloney, E.K.; D’Agostino, T.A. Communication skills training for oncology professionals. J. Clin. Oncol. 2012, 30, 1242–1247. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Butow, P.; Cockburn, J.; Girgis, A.; Bowman, D.; Schofield, P.; D’Este, C.; Stojanovski, E.; Tattersall, M.H.N. Increasing oncologists’ skills in eliciting and responding to emotional cues: Evaluation of a communication skills training program. Psycho-Oncology 2008, 17, 209–218. [Google Scholar] [CrossRef] [PubMed]
- Kissane, D.W.; Bultz, B.D.; Butow, P.N.; Noble, S.; Wilkinson, S. (Eds.) Oxford Textbook of Communication in Oncology and Palliative Care, 2nd ed.; Oxford University Press: Oxford, UK, 2017; 434p. [Google Scholar]
- Strong, V.; Waters, R.; Hibberd, C.; Murray, G.; Wall, L.; Walker, J.; McHugh, G.; Walker, A.; Sharpe, M. Management of depression for people with cancer (SMaRT oncology 1): A randomised trial. Lancet 2008, 372, 40–48. [Google Scholar] [CrossRef] [PubMed]
- Donovan, K.A.; Deshields, T.L.; Corbett, C.; Riba, M.B. Update on the Implementation of NCCN Guidelines for Distress Management by NCCN Member Institutions. J. Natl. Compr. Cancer Netw. 2019, 17, 1251–1256. [Google Scholar] [CrossRef] [PubMed]
- Meijer, A.; Roseman, M.; Delisle, V.C.; Milette, K.; Levis, B.; Syamchandra, A.; Stefanek, M.E.; Stewart, D.E.; de Jonge, P.; Coyne, J.C.; et al. Effects of screening for psychological distress on patient outcomes in cancer: A systematic review. J. Psychosom. Res. 2013, 75, 1–17. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Feldstain, A.; Tomei, C.; Bélanger, M.; Lebel, S. Screening for distress in patients with cancer: Methodologic considerations. Curr. Oncol. 2014, 21, 330–333. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Recklitis, C.J.; Blackmon, J.E.; Chang, G. Screening young adult cancer survivors with the PROMIS Depression Short Form (PROMIS-D-SF): Comparison with a structured clinical diagnostic interview. Cancer 2020, 126, 1568–1575. [Google Scholar] [CrossRef] [PubMed]
- Yedidia Moser, R.; Ben-Shimol, S.; Sagi, O.; Horev, A. Comparison between cutaneous leishmaniasis patients with facial and non-facial lesions. Int. J. Dermatol. 2021, 60, 1109–1113. [Google Scholar] [CrossRef] [PubMed]
- Mahoney, M.R.; Farmer, C.; Sinclair, S.; Sung, S.; Dehaut, K.; Chung, J.Y. Utilization of the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure-Adult to Screen Healthy Volunteers for Research Studies. Psychiatry Res. 2020, 286, 112822. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Association, A.P. DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure—Adult. Available online: https://www.heartandmindofiowa.com/storage/app/media/DSM-5-Self-Rated-Level-1-Cross-Cutting-Symptom-Measure-Adult-2.pdf (accessed on 1 March 2019).
- Mosheva, M.; Hertz-Palmor, N.; Dorman Ilan, S.; Matalon, N.; Pessach, I.M.; Afek, A.; Ziv, A.; Kreiss, Y.; Gross, R.; Gothelf, D. Anxiety, pandemic-related stress and resilience among physicians during the COVID-19 pandemic. Depress. Anxiety 2020, 37, 965–971. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- (PHO), P.H.O. PROMIS Emotional Distress—Anxiety—Short Form. Available online: https://www.psychiatry.org/getmedia/f284f967-ed9e-4754-99fc-b32765b1c4a0/APA-DSM5TR-Level2AnxietyAdult.pdf (accessed on 1 March 2019).
- (PHO), P.H.O. PROMIS Emotional Distress—Depression—Short Form. Available online: https://www.psychiatry.org/File%20Library/Psychiatrists/Practice/DSM/APA_DSM5_Level-2-Depression-Adult.pdf (accessed on 1 March 2019).
- Available online: https://www.psychiatry.org/psychiatrists/practice/dsm (accessed on 1 March 2019).
- Godby, R.C.; Dai, C.; Al-Obaidi, M.; Giri, S.; Young-Smith, C.; Kenzik, K.; McDonald, A.M.; Paluri, R.K.; Gbolahan, O.B.; Bhatia, S.; et al. Depression among older adults with gastrointestinal malignancies. J. Geriatr. Oncol. 2021, 12, 599–604. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Linden, W.; Vodermaier, A.; MacKenzie, R.; Greig, D. Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age. J. Affect. Disord. 2012, 141, 343–351. [Google Scholar] [CrossRef] [PubMed]
- Wilford, J.; Osann, K.; Hsieh, S.; Monk, B.; Nelson, E.; Wenzel, L. Validation of PROMIS emotional distress short form scales for cervical cancer. Gynecol. Oncol. 2018, 151, 111–116. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Ell, K.; Sanchez, K.; Vourlekis, B.; Lee, P.-J.; Dwight-Johnson, M.; Lagomasino, I.; Muderspach, L.; Russell, C. Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J. Clin. Oncol. 2005, 23, 3052–3060. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Levav, I. The treatment gap of depression in persons with cancer. Asian Pac. J. Cancer Prev. 2010, 11, 117–119. [Google Scholar] [PubMed]
- Leahy, D.; Donnelly, A.; Irwin, K.; D’Alton, P. Barriers and facilitators to accessing cancer care for people with significant mental health difficulties: A qualitative review and narrative synthesis. Psycho-Oncology 2021, 30, 2012–2022. [Google Scholar] [CrossRef] [PubMed]
- Passik, S.D.; Dugan, W.; McDonald, M.V.; Rosenfeld, B.; Theobald, D.E.; Edgerton, S. Oncologists’ recognition of depression in their patients with cancer. J. Clin. Oncol. 1998, 16, 1594–1600. [Google Scholar] [CrossRef] [PubMed]
- Dodd, S.; Mitchell, P.B.; Bauer, M.; Yatham, L.; Young, A.H.; Kennedy, S.H.; Williams, L.; Suppes, T.; Lopez Jaramillo, C.; Trivedi, M.H.; et al. Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement. World J. Biol. Psychiatry 2018, 19, 330–348. [Google Scholar] [CrossRef] [PubMed]
- Aizer, A.A.; Chen, M.-H.; McCarthy, E.P.; Mendu, M.L.; Koo, S.; Wilhite, T.J.; Graham, P.L.; Choueiri, T.K.; Hoffman, K.E.; Martin, N.E.; et al. Marital status and survival in patients with cancer. J. Clin. Oncol. 2013, 31, 3869–3876. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Cohen, S.D.; Sharma, T.; Acquaviva, K.; Peterson, R.A.; Patel, S.S.; Kimmel, P.L. Social support and chronic kidney disease: An update. Adv. Chronic Kidney Dis. 2007, 14, 335–344. [Google Scholar] [CrossRef] [PubMed]
- DiMatteo, M.R.; Lepper, H.S.; Croghan, T.W. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 2000, 160, 2101–2107. [Google Scholar] [CrossRef] [PubMed]
- Pampallona, S.; Bollini, P.; Tibaldi, G.; Kupelnick, B.; Munizza, C. Patient adherence in the treatment of depression. Br. J. Psychiatry 2002, 180, 104–109. [Google Scholar] [CrossRef] [PubMed]
- Vodermaier, A.; Linden, W.; MacKenzie, R.; Greig, D.; Marshall, C. Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer. Br. J. Cancer 2011, 105, 1814–1817. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Naser, A.Y.; Hameed, A.N.; Mustafa, N.; Alwafi, H.; Dahmash, E.Z.; Alyami, H.S.; Khalil, H. Depression and Anxiety in Patients With Cancer: A Cross-Sectional Study. Front. Psychol. 2021, 12, 585534. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Roughan, W.H.; Campos, A.I.; García-Marín, L.M.; Cuéllar-Partida, G.; Lupton, M.K.; Hickie, I.B.; Medland, S.E.; Wray, N.R.; Byrne, E.M.; Ngo, T.T.; et al. Comorbid Chronic Pain and Depression: Shared Risk Factors and Differential Antidepressant Effectiveness. Front. Psychiatry 2021, 12, 643609. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Mulder, R. Depression relapse: Importance of a long-term perspective. Lancet 2015, 386, 10–12. [Google Scholar] [CrossRef] [PubMed]
- Krebber, A.M.H.; Buffart, L.M.; Kleijn, G.; Riepma, I.C.; de Bree, R.; Leemans, C.R.; Becker, A.; Brug, J.; van Straten, A.; Cuijpers, P.; et al. Prevalence of depression in cancer patients: A meta-analysis of diagnostic interviews and self-report instruments. Psycho-Oncology 2014, 23, 121–130. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Asmundson, G.J.; Katz, J. Understanding the co-occurrence of anxiety disorders and chronic pain: State-of-the-art. Depress. Anxiety 2009, 26, 888–901. [Google Scholar] [CrossRef]
- Melnyk, H.; Djukic, M.; Merriman, J.; Vaughan Dickson, V. An integrative review: Women’s psychosocial vulnerability in relation to paid work after a breast cancer diagnosis. J. Adv. Nurs. 2021, 77, 2144–2154. [Google Scholar] [CrossRef] [PubMed]
- Tsaras, K.; Papathanasiou, I.V.; Mitsi, D.; Veneti, A.; Kelesi, M.; Zyga, S.; Fradelos, E.C. Assessment of Depression and Anxiety in Breast Cancer Patients: Prevalence and Associated Factors. Asian Pac. J. Cancer Prev. 2018, 19, 1661–1669. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Hashemi, S.-M.; Rafiemanesh, H.; Aghamohammadi, T.; Badakhsh, M.; Amirshahi, M.; Sari, M.; Behnamfar, N.; Roudini, K. Prevalence of anxiety among breast cancer patients: A systematic review and meta-analysis. Breast Cancer 2020, 27, 166–178. [Google Scholar] [CrossRef] [PubMed]
- Pitman, A.; Suleman, S.; Hyde, N.; Hodgkiss, A. Depression and anxiety in patients with cancer. BMJ 2018, 361, k1415. [Google Scholar] [CrossRef] [PubMed]
- Matud, M.P.; Bethencourt, J.M.; Ibáñez, I. Gender differences in psychological distress in Spain. Int. J. Soc. Psychiatry 2015, 61, 560–568. [Google Scholar] [CrossRef] [PubMed]
- Luckett, T.; Goldstein, D.; Butow, P.N.; Gebski, V.; Aldridge, L.J.; McGrane, J.; Ng, W.; King, M.T. Psychological morbidity and quality of life of ethnic minority patients with cancer: A systematic review and meta-analysis. Lancet Oncol. 2011, 12, 1240–1248. [Google Scholar] [CrossRef] [PubMed]
- Amiel, S.; Nijim, F.; Dolev, T. Bedouin Children in the Negev: Characteristics, Needs and Patterns of Service Use; Myers-JDC-Brookdale Institute: Jerusalem, Israel, 2009. [Google Scholar]
- Vitale, E.; Halemani, K.; Shetty, A.; Chang, Y.-C.; Hu, W.-Y.; Massafra, R.; Moretti, A. Sex Differences in Anxiety and Depression Conditions among Cancer Patients: A Systematic Review and Meta-Analysis. Cancers 2024, 16, 1969. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
Characteristics | Median (Interquartile Range) | |
---|---|---|
Age (years) | 67.0 (11) | |
Gender | ||
Male Female | 69.0 (8) Mean ± SD (range) 64.65 ± 10.57 (44–87) | |
Frequencies (percentage) | ||
Female | 60 (37.7) | |
Male | 99 (62.3) | |
Ethnicity | ||
Jewish | 91 (57.2) | |
Arab | 31 (19.5) | |
European descent | 37 (23.3) | |
Marital status | ||
Married | 105 (66.0) | |
Divorced | 25 (15.7) | |
Widowed | 14 (8.8) | |
Single | 11 (6.9) | |
In relationship | 4 (2.5) | |
Cancer metastasis | ||
Yes | 111 (69.8) | |
No | 48 (30.2) | |
Disease duration | ||
<1 month | 3 (1.9) | |
1–3 month | 19 (11.9) | |
3–6 month | 29 (18.2) | |
6–9 month | 18 (11.3) | |
9–12 month | 9 (5.7) | |
>1 year | 81 (50.9) | |
Cancer therapy | ||
Immunotherapy | 38 (23.9) | |
Chemotherapy | 69 (43.4) | |
Combination of immunotherapy and chemotherapy | 47 (29.6) | |
Radiotherapy | 5 (3.1) | |
Family history of malignancy | ||
Yes | 72 (45.3) | |
No | 87 (54.7) | |
Past mental health disorder | ||
Yes | 7 (4.4) | |
No | 152 (95.6) | |
Past antidepressant treatment | ||
Yes | 16 (10.1) | |
No | 143 (89.9) | |
Type of antidepressant treatment | ||
Psychotherapy | 2 (1.3) | |
Medications | 10 (6.3) | |
Combination | 4 (2.5) | |
Family history of diagnosed mental health disorder | ||
Yes | 6 (3.8) | |
No | 153 (96.2) | |
Are you feeling mental health worsening? | ||
Yes | 64 (40.3) | |
No | 95 (59.7) | |
Currently using pharmacology therapy | ||
Yes | 10 (6.3) | |
No | 149 (93.7) | |
Current psychiatric/psychological support | ||
Yes | 30 (18.9) | |
No | 129 (81.1) |
N | Mean | Median | Standard Deviation | Variance | Skewness Coefficient | |
---|---|---|---|---|---|---|
Age (Total) | 159 | 65.75 | 67 | 10.99 | 120.72 | −1.180 |
Female | 60 | 64.65 | 64.0 | 10.57 | 111.62 | 0.210 |
Male | 99 | 66.41 | 69.0 | 11.24 | 126.25 | −1.918 |
Severity of Depression | Prevalence (Percentage) |
---|---|
Normal | 123 (77.4) |
Mild depression | 21 (13.2) |
Moderate depression | 12 (7.5) |
Severe depression | 3 (1.9) |
Severity of anxiety | Prevalence (percentage) |
Normal | 111 (69.8) |
Mild anxiety | 24 (15.1) |
Moderate anxiety | 21 (13.2) |
Severe anxiety | 3 (1.9) |
PROMIS T-Score | N | Mean | Median | Standard Deviation | Variance | Skewness Coefficient |
---|---|---|---|---|---|---|
Depression | 159 | 46.56 | 46.20 | 9.16 | 83.90 | 0.61 |
Anxiety | 159 | 48.64 | 48.40 | 9.99 | 99.88 | 0.26 |
Liver Cancer | Renal Cancer | Pancreas Cancer | Brain Cancer | Skin Cancer | Sarcoma Cancer | Prostate Cancer | Neck Cancer | Colorectal Cancer | Stomach Cancer | Uterine Cancer | Lung Cancer | Breast Cancer | Ovarian Cancer | Bladder Cancer | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Depression severity | |||||||||||||||
Normal | 5 (100.0) | 3 (60.0) | 3 (42.9) | 0 | 22 (88.0) | 3 (50.0) | 6 (85.7) | 0 | 22 (81.5) | 7 (87.5) | 0 | 29 (78.4) | 16 (76.2) | 5 (100.0) | 2 (100.0) |
Mild depression | 0 | 1 (20.0) | 2 (28.6) | 1 (100.0) | 1 (4.0) | 1 (16.7) | 1 (14.3) | 1 (50.0) | 3 (11.1) | 0 | 0 | 7 (18.9) | 3 (14.3) | 0 | 0 |
Moderate depression | 0 | 1 (20.0) | 2 (28.6) | 0 | 2 (8.0) | 1 (16.7) | 0 | 1 (50.0) | 2 (7.4) | 0 | 1 (100.0) | 1 (2.7) | 1 (4.8) | 0 | 0 |
Severe depression | 0 | 0 | 0 | 0 | 0 | 1 (16.7) | 0 | 0 | 0 | 1 (12.5) | 0 | 0 | 1 (4.8) | 0 | 0 |
Total | 5 (3.1) | 5 (3.1) | 7 (4.4) | 1 (0.6) | 25 (15.7) | 6 (3.8) | 7 (4.4) | 2 (1.3) | 27 (17.0) | 8 (5.0) | 1 (0.6) | 37 (23.3) | 21 (13.2) | 5 (3.1) | 2 (1.3) |
Anxiety severity | |||||||||||||||
Normal | 5 (100.0) | 4 (80.0) | 4 (57.1) | 0 | 18 (72.0) | 3 (50.0) | 6 (85.7) | 0 | 19 (70.4) | 6 (75.0) | 0 | 27 (73.0) | 13 (61.9) | 4 (80.0) | 2 (100.0) |
Mild anxiety | 0 | 0 | 1 (14.3) | 1 (100.0) | 3 (12.0) | 1 (16.7) | 1 (14.3) | 2 (100.0) | 4 (14.8) | 0 | 0 | 7 (18.9) | 3 (14.3) | 1 (20.0) | 0 |
Moderate anxiety | 0 | 1 (20.0) | 2 (28.6) | 0 | 3 (12.0) | 1 (16.7) | 0 | 0 | 4 (14.8) | 2 (25.0) | 1 (100.0) | 3 (8.1) | 4 (19.0) | 0 | 0 |
Severe anxiety | 0 | 0 | 0 | 0 | 1 (4.0) | 1 (16.7) | 0 | 0 | 0 | 0 | 0 | 0 | 1 (4.8) | 0 | 0 |
Total | 5 (3.1) | 5 (3.1) | 7 (4.4) | 1 (0.6) | 25 (15.7) | 6 (3.8) | 7 (4.4) | 2 (1.3) | 27 (17.0) | 8 (5.0) | 1 (0.6) | 37 (23.3) | 21 (13.2) | 5 (3.1) | 2 (1.3) |
Variable | Odds Ratio for Depression; CI 95% | p-Value for Depression | Odds ratio for Anxiety; CI 95%, p-Value | p-Value for Anxiety |
---|---|---|---|---|
Gender | ||||
Female (reference) | 1 | 1 | ||
Male | 1.56; 0.48–5.05 | 0.462 | 2.55; 0.86–7.59 | 0.093 |
Marital status | ||||
Married (reference) | 1 | 1 | ||
Divorced | 1.28; 0.39–4.20 | 0.688 | 1.97; 0.71–5.48 | 0.195 |
Widowed | 0.88; 0.16–4.94 | 0.881 | 0.25; 0.03–2.23 | 0.214 |
Single | 10.89; 2.44–48.64 | 0.002 | 2.89; 0.71–11.71 | 0.137 |
In relationship | 0; | 0.999 | 1.51; 0.13–17.37 | 0.740 |
Duration of disease | ||||
<1 year (reference) | 1 | 1 | ||
>1 year | 1.41; 0.56–3.54 | 0.464 | 2.65; 1.15–6.08 | 0.022 |
Metastasis | ||||
No (reference) | 1 | 1 | ||
Yes | 3.66; 1.11–12.01 | 0.033 | 1.17; 0.49–2.79 | 0.722 |
Cancer therapy | ||||
Immunotherapy (reference) | 1 | 1 | ||
Chemotherapy | 1.27; 0.31–5.26 | 0.742 | 0.46; 0.12–1.67 | 0.236 |
Combination of immunotherapy and chemotherapy | 0.54; 0.11–2.51 | 0.428 | 0.26; 0.06–1.03 | 0.056 |
Radiotherapy | 2.80; 0.26–29.75 | 0.394 | 1.06; 0.11–9.91 | 0.962 |
Ethnicity | ||||
Jewish (reference) | 1 | 1 | ||
Arab | 1.30; 0.44–3.85 | 0.634 | 1.75; 0.63–4.88 | 0.284 |
European descent | 0.88; 0.27–2.87 | 0.834 | 1.12; 0.42–2.97 | 0.819 |
Age | ||||
Less than 65 (reference) | 1 | 1 | ||
65 years and above | 0.75; 0.30–1.90 | 0.549 | 0.47; 0.20–1.07 | 0.072 |
Type of cancer | ||||
Skin (reference) | 1 | 1 | ||
Colon | 3.10; 0.38–25.69 | 0.294 | 3.21; 0.57–17.78 | 0.182 |
Lung | 5.0; 0.72–34.92 | 0.104 | 2.71; 0.59–12.52 | 0.202 |
Female-specific (breast, ovarian, uterine) | 8.53; 0.83–87.41 | 0.071 | 7.78; 1.05–57.96 | 0.045 |
Other | 6.40; 0.94–43.72 | 0.058 | 2.69; 0.56–12.88 | 0.217 |
Past mental treatment | ||||
No (reference) | 1 | 1 | ||
Yes | 4.30; 1.12–16.48 | 0.033 | 2.10; 0.61–7.25 | 0.239 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Shalata, W.; Gothelf, I.; Bernstine, T.; Michlin, R.; Tourkey, L.; Shalata, S.; Yakobson, A. Mental Health Challenges in Cancer Patients: A Cross-Sectional Analysis of Depression and Anxiety. Cancers 2024, 16, 2827. https://doi.org/10.3390/cancers16162827
Shalata W, Gothelf I, Bernstine T, Michlin R, Tourkey L, Shalata S, Yakobson A. Mental Health Challenges in Cancer Patients: A Cross-Sectional Analysis of Depression and Anxiety. Cancers. 2024; 16(16):2827. https://doi.org/10.3390/cancers16162827
Chicago/Turabian StyleShalata, Walid, Itamar Gothelf, Tomer Bernstine, Regina Michlin, Lena Tourkey, Sondos Shalata, and Alexander Yakobson. 2024. "Mental Health Challenges in Cancer Patients: A Cross-Sectional Analysis of Depression and Anxiety" Cancers 16, no. 16: 2827. https://doi.org/10.3390/cancers16162827
APA StyleShalata, W., Gothelf, I., Bernstine, T., Michlin, R., Tourkey, L., Shalata, S., & Yakobson, A. (2024). Mental Health Challenges in Cancer Patients: A Cross-Sectional Analysis of Depression and Anxiety. Cancers, 16(16), 2827. https://doi.org/10.3390/cancers16162827